Boston Scientific Statistics

Total Valuation

Boston Scientific has a market cap or net worth of GBP 104.27 billion. The enterprise value is 111.43 billion.

Market Cap	104.27B
Enterprise Value	111.43B

Important Dates

The next estimated earnings date is Friday, January 31, 2025.

Earnings Date	Jan 31, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+1.89%
Shares Change (QoQ)	+0.22%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.47B

Valuation Ratios

The trailing PE ratio is 77.95.

PE Ratio	77.95
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 33.66, with an EV/FCF ratio of 69.27.

EV / Earnings	83.30
EV / Sales	8.81
EV / EBITDA	33.66
EV / EBIT	49.52
EV / FCF	69.27

Financial Position

The company has a current ratio of 1.48, with a Debt / Equity ratio of 0.54.

Current Ratio	1.48
Quick Ratio	0.85
Debt / Equity	0.54
Debt / EBITDA	2.70
Debt / FCF	5.22
Interest Coverage	9.76

Financial Efficiency

Return on equity (ROE) is 8.92% and return on invested capital (ROIC) is 5.83%.

Return on Equity (ROE)	8.92%
Return on Assets (ROA)	4.90%
Return on Capital (ROIC)	5.83%
Revenue Per Employee	247,317
Profits Per Employee	27,870
Employee Count	48,000
Asset Turnover	0.44
Inventory Turnover	1.93

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +59.07% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+59.07%
50-Day Moving Average	88.40
200-Day Moving Average	78.89
Relative Strength Index (RSI)	45.40
Average Volume (20 Days)	9,727

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.09

Income Statement

In the last 12 months, Boston Scientific had revenue of GBP 11.87 billion and earned 1.34 billion in profits. Earnings per share was 0.90.

Revenue	11.87B
Gross Profit	8.16B
Operating Income	2.11B
Pretax Income	1.64B
Net Income	1.34B
EBITDA	3.03B
EBIT	2.11B
Earnings Per Share (EPS)	0.90

Full Income Statement

Balance Sheet

The company has 1.87 billion in cash and 8.40 billion in debt, giving a net cash position of -6.53 billion.

Cash & Cash Equivalents	1.87B
Total Debt	8.40B
Net Cash	-6.53B
Net Cash Per Share	n/a
Equity (Book Value)	15.64B
Book Value Per Share	10.49
Working Capital	2.13B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.19 billion and capital expenditures -581.96 million, giving a free cash flow of 1.61 billion.

Operating Cash Flow	2.19B
Capital Expenditures	-581.96M
Free Cash Flow	1.61B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 68.74%, with operating and profit margins of 17.78% and 11.26%.

Gross Margin	68.74%
Operating Margin	17.78%
Pretax Margin	13.83%
Profit Margin	11.26%
EBITDA Margin	25.54%
EBIT Margin	17.78%
FCF Margin	13.55%

Dividends & Yields

Boston Scientific does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.89%
Shareholder Yield	-1.89%
Earnings Yield	1.27%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Boston Scientific has an Altman Z-Score of 4.3.

Altman Z-Score	4.3
Piotroski F-Score	n/a